UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 21, 2013

 

ENTREMED, INC.

(Exact Name of Registrant as Specified in its Charter)

 

DELAWARE 0-20713 58-1959440
(State or other jurisdiction  of (Commission File Number) (IRS Employer Identification
incorporation or organization)   No.)

 

9620 Medical Center Drive, Suite 300

Rockville, Maryland

 

 

(Address of principal executive offices)

 

20850

 

 

(Zip Code)

 

(240) 864-2600

 

 

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the

registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 
 

 

Item 2.02 Results of Operations and Financial Condition.

 

On March 21, 2013, EntreMed, Inc. (the “Company”) issued a press release reporting its financial results for the three month period and fiscal year ending December 31, 2012. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

The information on this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d)   Exhibits
     
99.1   Press Release of EntreMed, Inc., dated March 21, 2013

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ENTREMED, INC.
   
  /s/ Sara B. Capitelli  
   
  Sara B. Capitelli
  Vice President, Finance and Principal Accounting Officer
   
Date:  March 21, 2013  

 

 
 

 

EXHIBIT INDEX

 

Exhibit Number   Description of Document
     
99.1   Press Release of EntreMed, Inc., dated March 21, 2013